The findings of our study demonstrate that SSC enhances fatty acid oxidation by activating PPARα-mediated gene transcription and increases CPT1 and ACOX1 activity, thereby counteracting hepatic steatosis. The gene discussed is CPT1A; the disease is Hepatic steatosis.